chlorpromazine has been researched along with mitomycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, XJ; Liu, JF; Yu, CL | 1 |
| Budihna, M; Furlan, L; Lesnicar, H; Rudolf, Z; Smid, L; Soba, E; Zakotnik, B; Zargi, M | 1 |
| Lialiaris, TS; Mourelatos, C; Papachristou, F; Simopoulou, M | 1 |
| Figat, R; Pietrosiuk, A; Śliwińska, A; Sobczak, M; Soluch, A; Stochmal, A; Sykłowska-Baranek, K; Zgadzaj, A | 1 |
1 review(s) available for chlorpromazine and mitomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for chlorpromazine and mitomycin
| Article | Year |
|---|---|
Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer--preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chlorpromazine; Combined Modality Therapy; Dicumarol; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Niacinamide; Prospective Studies; Radiotherapy Dosage | 1995 |
6 other study(ies) available for chlorpromazine and mitomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
[Protective effects of total saponins of semen Ziziphi spinosae on cultured rat myocardial cells].
Topics: Animals; Cells, Cultured; Chlorpromazine; Drugs, Chinese Herbal; L-Lactate Dehydrogenase; Mitomycin; Mitomycins; Myocardium; Rats; Rats, Inbred Strains; Saponins | 1990 |
Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.
Topics: Animals; Antineoplastic Agents; Caffeine; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Proliferation; Cells, Cultured; Chlorpromazine; Drug Synergism; Drug Therapy, Combination; Humans; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mitomycin; Sister Chromatid Exchange; Survival Analysis | 2009 |
Antigenotoxic, Anti-photogenotoxic, and Antioxidant Properties of
Topics: Animals; Antimutagenic Agents; Antioxidants; Araliaceae; Chlorpromazine; DNA Damage; Male; Mitomycin; Plant Extracts; Plant Shoots; Rats; Rats, Sprague-Dawley | 2020 |